October 24, 2020

The Niche

Knoepfler lab stem cell blog

Month: February 2016

4 min read

A great new piece in The New Yorker by Dana Goodyear, The Stress Test, gives us a window into Charles Vacanti’s side of the STAP cell mess and includes recent quotes from him. It’s a long, fascinating look inside of STAP, the tangled and ultimately tragic scientific implosion that created and then brought down two Nature papers and some careers. The most notable part of the article is that the stem cell community finally hears from Vacanti, postdoc mentor of lead author Haruko Obokata. We …Read More

2 min read

Last month the stem cell community learned that a patient of the business US Stem Cell Inc./US Stem Cell Clinic, previously known as Bioheart, had filed suit in a Broward County Florida Court against the publicly traded company alleging various charges including damage to her eye. Now US Stem Cell has more recently filed suit in the same court against one or more anonymous online critics for libel/slander. In this new case, US Stem Cell Inc versus John Doe, et al, the company points to specific …Read More

2 min read

My new book GMO Sapiens just recently came out. You can see a few reviews of it here and you can order it here. It’s an approachable, quick read on the unsettling, but exciting topic of using CRISPR gene editing technology to make a new kind of people. Here’s an excerpt from the book (publisher: World Scientific Publishing Company), where I’m discussing the possibility that human genetic modification via CRISPR could become popular and an unstoppable trend: The reality is that we just do not …Read More

1 min read

There has been a lot of excitement this week about a press release from stem cell biotech Athersys that reported that treatment of stroke patients with its product MultiStem was associated with a statistically significant improvement at 1-year. This sounds encouraging and the stock has spiked up as a result. However, there are some naysayers including long-time stem cell biotech critic Adam Feuerstein, who today painted the Athersys press release as little more than spin. Feuerstein went through a list of what he describes …Read More